ampicillin has been researched along with dalfopristin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Messick, CR; Pendland, SL; Rodvold, KA | 1 |
| Lavin, B; Talbot, GH; Thompson, RL | 1 |
2 other study(ies) available for ampicillin and dalfopristin
| Article | Year |
|---|---|
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
Topics: Ampicillin; Chloramphenicol; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Kinetics; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1999 |
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Recurrence; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2003 |